Cara Therapeutics (Germany) Price Prediction
| 69C Stock | EUR 4.84 0.00 0.00% |
Oversold Vs Overbought
72
Oversold | Overbought |
Using Cara Therapeutics hype-based prediction, you can estimate the value of Cara Therapeutics from the perspective of Cara Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cara Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Cara because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cara Therapeutics after-hype prediction price | EUR 4.84 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cara |
Cara Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Cara Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cara Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cara Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cara Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Cara Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cara Therapeutics' historical news coverage. Cara Therapeutics' after-hype downside and upside margins for the prediction period are 0.24 and 15.07, respectively. We have considered Cara Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cara Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Cara Therapeutics is based on 3 months time horizon.
Cara Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cara Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cara Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cara Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.42 | 10.23 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.84 | 4.84 | 0.00 |
|
Cara Therapeutics Hype Timeline
Cara Therapeutics is presently traded for 4.84on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cara is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is presently at 1.42%. %. The volatility of related hype on Cara Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 4.84. About 16.0% of the company shares are owned by insiders or employees . The book value of Cara Therapeutics was presently reported as 3.44. The company recorded a loss per share of 1.5. Cara Therapeutics had not issued any dividends in recent years. The entity had 12:1 split on the 25th of October 2024. Assuming the 90 days horizon the next estimated press release will be in 5 to 10 days. Check out Cara Therapeutics Basic Forecasting Models to cross-verify your projections.Cara Therapeutics Related Hype Analysis
Having access to credible news sources related to Cara Therapeutics' direct competition is more important than ever and may enhance your ability to predict Cara Therapeutics' future price movements. Getting to know how Cara Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cara Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KWO | Transport International Holdings | 0.00 | 0 per month | 0.00 | (0.05) | 2.13 | (3.06) | 15.06 | |
| GZ3 | Yuexiu Transport Infrastructure | 0.00 | 0 per month | 2.19 | 0.11 | 6.06 | (4.35) | 39.76 | |
| GKE | Hisense Home Appliances | 0.00 | 0 per month | 2.41 | 0.05 | 4.56 | (3.95) | 13.04 | |
| 9GY | USWE SPORTS AB | 0.00 | 0 per month | 1.46 | 0.18 | 5.33 | (3.53) | 21.30 | |
| NRSA | NTG Nordic Transport | 0.00 | 0 per month | 0.00 | (0.26) | 1.89 | (2.63) | 8.60 | |
| 8AHB | Autohome ADR | 0.00 | 0 per month | 0.00 | (0.04) | 4.17 | (3.94) | 13.84 | |
| AS7 | ANTA SPORTS PRODUCT | 0.00 | 0 per month | 0.00 | (0.04) | 3.94 | (3.43) | 13.60 | |
| A41 | Addus HomeCare | 0.00 | 0 per month | 1.68 | 0.02 | 4.27 | (2.61) | 10.93 |
Cara Therapeutics Additional Predictive Modules
Most predictive techniques to examine Cara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cara using various technical indicators. When you analyze Cara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cara Therapeutics Predictive Indicators
The successful prediction of Cara Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cara Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cara Therapeutics based on analysis of Cara Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cara Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cara Therapeutics's related companies.
Story Coverage note for Cara Therapeutics
The number of cover stories for Cara Therapeutics depends on current market conditions and Cara Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cara Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cara Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Cara Therapeutics Short Properties
Cara Therapeutics' future price predictability will typically decrease when Cara Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cara Therapeutics often depends not only on the future outlook of the potential Cara Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cara Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 53.5 M |
Complementary Tools for Cara Stock analysis
When running Cara Therapeutics' price analysis, check to measure Cara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutics is operating at the current time. Most of Cara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutics' price. Additionally, you may evaluate how the addition of Cara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |